logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
M

Murtuza Bharmal

Research and Development Institute

21H指数
151论文数
2.5K被引数
收录论文 72
发表时间
logo
Criteria Used to Determine Platinum Eligibility in Patients with Metastatic Urothelial Carcinoma: Results of a Physician Survey in Five European Countries用于确定转移性尿路上皮癌患者顺铂适用性的标准：来自五个欧洲国家医师调查的结果
errEuropean Urology Open Science
IF4.5
err2025-09-23
err0
PREAI
errShilpa Gupta; Thomas Powles; Mairead Kearney; Laura Panattoni; Natalie Land; Thomas Flottemesch; Patrick Sullivan; Melissa Kirker; Murtuza Bharmal; Silke Guenther; Nuno Costa; Enrique Grande
err分享
err收藏
Real-world evidence in the reassessment of oncology therapies: payer perceptions from five countries
errFUTURE ONCOLOGY
IF2.6
err2024-04-04
err0
errOAAI
errBharmal, Murtuza; Katsoulis, Ioannis; Chang, Jane; Graham, Alex; Stavropoulou, Apostolina; Jhingran, Priti; Pashos, Chris L.
err分享
err收藏
Patient and Caregiver Perceptions of Advanced Bladder Cancer Systemic Treatments: Infodemiology Study Based on Social Media Data
errJMIR CANCER
IF2.7
err2023-03-27
err2
errOAAI
errRenner, Simon; Loussikian, Paul; Foulquie, Pierre; Marrel, Alexia; Barbier, Valentin; Mebarki, Adel; Schueck, Stephane; Bharmal, Murtuza
err分享
err收藏
Preferences for first-line treatment of advanced urothelial carcinoma among US practicing oncologists and patients
errFUTURE ONCOLOGY
IF2.6
err2023-03-06
err9
errOAAI
errGrivas, Petros; Veeranki, Phani; Chiu, Kevin; Pawar, Vivek; Chang, Jane; Bharmal, Murtuza
err分享
err收藏
Perceived Unmet Needs in Patients Living With Advanced Bladder Cancer and Their Caregivers: Infodemiology Study Using Data From Social Media in the United States
errJMIR CANCER
IF2.7
err2022-09-20
err6
errOAAI
errRenner, Simon; Loussikian, Paul; Foulquie, Pierre; Arnould, Benoit; Marrel, Alexia; Barbier, Valentin; Mebarki, Adel; Schuck, Stephane; Bharmal, Murtuza
err分享
err收藏
Systematic literature review of current treatments for stage I-III Merkel cell carcinoma
errFUTURE ONCOLOGY
IF2.6
err2021-09-08
err5
errOAAI
errPalencia, Roberto; Sandhu, Amrita; Webb, Sarah; Blaikie, Tom; Bharmal, Murtuza
err分享
err收藏
How Assessment-Schedule Matching Limits Bias When Comparing Progression-Free Survival in Single-Arm Studies: An Application in Second-Line Urothelial Carcinoma Treatments在比较单臂研究中的无进展生存期时，评估时间表匹配如何限制偏倚: 在二线尿路上皮癌治疗中的应用
errVALUE IN HEALTH
IF6
err2021-08-01
err2
errOAAI
errKapetanakis, Venediktos; Prawitz, Thibaud; Schlichting, Michael; Ishak, Jack; Phatak, Hemant; Yu, Ting; Bharmal, Murtuza
err分享
err收藏
What is the Impact of the Analysis Method Used for Health State Utility Values on QALYs in Oncology? A Simulation Study Comparing Progression-Based and Time-to-Death Approaches
errAPPLIED HEALTH ECONOMICS AND HEALTH POLICY
IF3.3
err2020-12-14
err4
errOAAI
errHatswell, Anthony J.; Bullement, Ash; Schlichting, Michael; Bharmal, Murtuza
err分享
err收藏
Health-related quality of life trajectory of treatment-naive patients with Merkel cell carcinoma receiving avelumab接受avelumab治疗的默克尔细胞癌患者的健康相关生活质量轨迹
errFUTURE ONCOLOGY
IF2.6
err2020-09-17
err3
errOAAI
errBharmal, Murtuza; Nolte, Sandra; Lebbe, Celeste; Mortier, Laurent; Brohl, Andrew S.; Fazio, Nicola; Grob, Jean-Jacquez; Pusceddu, Sara; Hanna, Glenn J.; Hassel, Jessica C.; Kiecker, Felix; Ellers-Lenz, Barbara; Bajars, Marcis; Guezel, Guelseren; Nghiem, Paul; Hunger, Matthias; Schlichting, Michael; Henry-Szatkowski, Mickael; D'Angelo, Sandra P.
err分享
err收藏
Non-progression with avelumab treatment in patients with metastatic Merkel cell carcinoma (mMCC) is associated with a clinically meaningful better health-related quality of life compared with progressive disease
errANNALS OF ONCOLOGY
IF65.4
err2020-09-01
err0
errOAAI
errBharmal, M.; Nolte, S.; Lebbe, C.; Mortier, L.; Brohl, A. S.; Fazio, N.; Grob, J-J.; Prinzi, N.; Hanna, G. J.; Hassel, J.; Kiecker, F.; Ellers-Lenz, B.; Bajars, M.; Guezel, G.; Nghiem, P.; Hunger, M.; Schlichting, M.; Henry-Szatkowski, M.; D'Angelo, S.
err分享
err收藏
Patient Experiences with Avelumab in Treatment-Naive Metastatic Merkel Cell Carcinoma: Longitudinal Qualitative Interview Findings from JAVELIN Merkel 200, a Registrational Clinical Trial
errPATIENT-PATIENT CENTERED OUTCOMES RESEARCH
IF3.1
err2020-05-30
err12
errOAAI
errLambert, Jeremy; Marrel, Alexia; D'Angelo, Sandra P.; Burgess, Melissa A.; Chmielowski, Bartosz; Fazio, Nicola; Gambichler, Thilo; Grob, Jean-Jacques; Lebbe, Celeste; Robert, Caroline; Russell, Jeffrey; Guezel, Guelseren; Bharmal, Murtuza
err分享
err收藏
Update on the psychometric properties and minimal important difference (MID) thresholds of the FACT-M questionnaire for use in treatment-naive and previously treated patients with metastatic Merkel cell carcinoma
errHEALTH AND QUALITY OF LIFE OUTCOMES
IF3.4
err2020-05-19
err6
errOAAI
errBharmal, Murtuza; Nolte, Sandra; Henry-Szatkowski, Mickael; Hennessy, Meliessa; Schlichting, Michael
err分享
err收藏
Evaluation of survival extrapolation in immuno-oncology using multiple pre-planned data cuts: learnings to aid in model selection
errBMC MEDICAL RESEARCH METHODOLOGY
IF3.4
err2020-05-06
err13
errOAAI
errBullement, Ash; Willis, Anna; Amin, Amerah; Schlichting, Michael; Hatswell, Anthony James; Bharmal, Murtuza
err分享
err收藏
Psychometric Properties of EQ-5D-5L Scoring Algorithms for the United Kingdom in Metastatic Merkel Cell Carcinoma
errVALUE IN HEALTH
IF6
err2019-10-01
err2
errOAAI
errBharmal, Murtuza; Hunger, Matthias; Schlichting, Michael
err分享
err收藏
Survival Analysis in Patients with Metastatic Merkel Cell Carcinoma Treated with AvelumabAvelumab治疗转移性Merkel细胞癌患者的生存分析
errADVANCES IN THERAPY
IF4
err2019-07-26
err11
errOAAI
errLanitis, Tereza; Proskorovsky, Irina; Ambavane, Apoorva; Hunger, Matthias; Zheng, Ying; Bharmal, Murtuza; Phatak, Hemant
err分享
err收藏
REVIEW OF THE APPLICATION OF HEALTH-RELATED QUALITY OF LIFE (HRQOL) DATA IN RECENT HEALTH TECHNOLOGY ASSESSMENTS (HTAS) OF CANCER IMMUNOTHERAPIES (IOS) BY THE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE (NICE)
errVALUE IN HEALTH
IF6
err2019-05-01
err0
errOAAI
errBullement, A.; Shields, G.; Hatswell, A. J.; Schlichting, M.; Bharmal, M.
err分享
err收藏
SHOULD HEALTH STATE UTILITY VALUES (HSUVS) IN CANCER IMMUNOTHERAPIES (IOS) BE ANALYZED BY TIME TO DEATH (TTD) OR PROGRESSION STATUS? RESULTS OF A SIMULATION STUDY
errVALUE IN HEALTH
IF6
err2019-05-01
err0
errOAAI
errHatswell, A. J.; Bullement, A.; Schlichting, M.; Bharmal, M.
err分享
err收藏
Psychometric properties of the FACT-M questionnaire in patients with Merkel cell carcinoma (vol 15, 247, 2017)
errHEALTH AND QUALITY OF LIFE OUTCOMES
IF3.4
err2019-03-27
err0
errOAAI
errBharmal, Murtuza; Fofana, Fatoumata; Barbosa, Carla Dias; Williams, Paul; Mahnke, Lisa; Marrel, Alexia; Schlichting, Michael
err分享
err收藏
ASSESSING THE POTENTIAL VALUE OF AN INNOVATIVE ONCOLOGY THERAPY FROM THE HEALTH TECHNOLOGY ASSESSMENT (HTA) PERSPECTIVE: MARRYING CLINICAL VALUE FRAMEWORKS WITH ECONOMIC ASSESSMENT METHODOLOGY
errVALUE IN HEALTH
IF6
err2018-10-01
err0
errOAAI
errZheng, Y.; Lanitis, T.; Ambavane, A.; Proskorovsky, I; Bharmal, M.; Phatak, H.
err分享
err收藏
DIRECT HEALTHCARE COSTS BY TREATMENT AMONG PATIENTS WITH MERKEL CELL CARCINOMA (MCC) IN THE UNITED STATES
errVALUE IN HEALTH
IF6
err2018-10-01
err1
errOAAI
errKearney, M.; Thokagevistk, K.; Boutmy, E.; Sherman, S.; Bharmal, M.
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
D
Dirk Schadendorf
H 指数: 182 · 论文数: 2.4K
C
Caroline Robert
H 指数: 154 · 论文数: 1.5K
J
Jean‐Jacques Grob
H 指数: 107 · 论文数: 1.0K
C
Célèste Lebbé
H 指数: 94 · 论文数: 1.2K
J
Jürgen C. Becker
H 指数: 93 · 论文数: 865
查看更多